Ken Griffin’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Ken Griffin's RCUS Position: Q3 2026 in Review
Ken Griffin reduced its Arcus Biosciences (RCUS) stake by 5.6% in Q3 2026, selling an estimated $4.94M and leaving 2,959,746 shares worth $76.5M. The position accounts for 0.01% of the portfolio, ranked #1187.
Ken Griffin first reported a position in RCUS in Q1 2019 and has held it in 31 quarters since. The position peaked at $96.7M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Ken Griffin held 2,959,746 shares of Arcus Biosciences worth $76.5M as of Q3 2026.
- Ken Griffin sold 175,311 Arcus Biosciences shares in Q3 2026, an estimated $4.94M.
- Arcus Biosciences made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1187 holding.
- Ken Griffin first reported a position in Arcus Biosciences in Q1 2019 and has held it in 31 quarters since.
- Ken Griffin's Arcus Biosciences position peaked at $96.7M in Q2 2026.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.